Patents Assigned to SERB SA
  • Methods of administering 3,4-diaminopridine
    Patent number: 11873525
    Abstract: Provided herein are methods of determining NAT acetylation status of a subject with a 3,4-DAP-sensitive disease, methods of selecting a dose of 3,4-DAP or a pharmaceutically acceptable salt thereof adjusted to a subject's acetylation status, methods of administering 3,4-diaminopyridine or a pharmaceutically acceptable salt thereof to a patient in need thereof, and methods of treating 3,4-DAP sensitive diseases.
    Type: Grant
    Filed: May 23, 2023
    Date of Patent: January 16, 2024
    Assignee: SERB SA
    Inventors: Marvin R. Garovoy, Peter E. Haroldsen, Donald G. Musson
  • Methods of administering 3,4-diaminopridine
    Patent number: 11845977
    Abstract: Provided herein are methods of determining NAT acetylation status of a subject with a 3,4-DAP-sensitive disease, methods of selecting a dose of 3,4-DAP or a pharmaceutically acceptable salt thereof adjusted to a subject's acetylation status, methods of administering 3,4-diaminopyridine or a pharmaceutically acceptable salt thereof to a patient in need thereof, and methods of treating 3,4-DAP sensitive diseases.
    Type: Grant
    Filed: May 23, 2023
    Date of Patent: December 19, 2023
    Assignee: SERB SA
    Inventors: Marvin R. Garovoy, Peter E. Haroldsen, Donald G. Musson
  • Methods of administering 3,4-diaminopyridine
    Patent number: 11274332
    Abstract: Provided herein are methods of determining NAT acetylation status of a subject with a 3,4-DAP-sensitive disease, methods of selecting a dose of 3,4-DAP or a pharmaceutically acceptable salt thereof adjusted to a subject's acetylation status, methods of administering 3,4-diaminopyridine or a pharmaceutically acceptable salt thereof to a patient in need thereof, and methods of treating 3,4-DAP sensitive diseases.
    Type: Grant
    Filed: October 15, 2021
    Date of Patent: March 15, 2022
    Assignee: SERB SA
    Inventors: Marvin R. Garovoy, Peter E. Haroldsen, Donald G. Musson
  • Methods of administering 3,4-diaminopyridine
    Patent number: 11274331
    Abstract: Provided herein are methods of determining NAT acetylation status of a subject with a 3,4-DAP-sensitive disease, methods of selecting a dose of 3,4-DAP or a pharmaceutically acceptable salt thereof adjusted to a subject's acetylation status, methods of administering 3,4-diaminopyridine or a pharmaceutically acceptable salt thereof to a patient in need thereof, and methods of treating 3,4-DAP sensitive diseases.
    Type: Grant
    Filed: October 15, 2021
    Date of Patent: March 15, 2022
    Assignee: SERB SA
    Inventors: Marvin R. Garovoy, Peter E. Haroldsen, Donald G. Musson
  • Methods of administering 3,4-diaminopyridine
    Patent number: 11268128
    Abstract: Provided herein are methods of determining NAT acetylation status of a subject with a 3,4-DAP-sensitive disease, methods of selecting a dose of 3,4-DAP or a pharmaceutically acceptable salt thereof adjusted to a subject's acetylation status, methods of administering 3,4-diaminopyridine or a pharmaceutically acceptable salt thereof to a patient in need thereof, and methods of treating 3,4-DAP sensitive diseases.
    Type: Grant
    Filed: October 15, 2021
    Date of Patent: March 8, 2022
    Assignee: SERB SA
    Inventors: Marvin R. Garovoy, Peter E. Haroldsen, Donald G. Musson
  • Methods of administering 3,4-diaminopyridine
    Patent number: 11060128
    Abstract: Provided herein are methods of determining NAT acetylation status of a subject with a 3,4-DAP-sensitive disease, methods of selecting a dose of 3,4-DAP or a pharmaceutically acceptable salt thereof adjusted to a subject's acetylation status, methods of administering 3,4-diaminopyridine or a pharmaceutically acceptable salt thereof to a patient in need thereof, and methods of treating 3,4-DAP sensitive diseases.
    Type: Grant
    Filed: September 1, 2020
    Date of Patent: July 13, 2021
    Assignee: SERB SA
    Inventors: Marvin R. Garovoy, Peter E. Haroldsen, Donald G. Musson
  • Methods of administering 3,4-diaminopyridine
    Patent number: 10793893
    Abstract: Provided herein are methods of determining NAT acetylation status of a subject with a 3,4-DAP-sensitive disease, methods of selecting a dose of 3,4-DAP or a pharmaceutically acceptable salt thereof adjusted to a subject's acetylation status, methods of administering 3,4-diaminopyridine or a pharmaceutically acceptable salt thereof to a patient in need thereof, and methods of treating 3,4-DAP sensitive diseases.
    Type: Grant
    Filed: June 29, 2012
    Date of Patent: October 6, 2020
    Assignee: SERB SA
    Inventors: Marvin R. Garovoy, Peter E. Haroldsen, Donald G. Musson